Efficacy of Bumetanide to Improve Cognitive Functions in Down Syndrome

NCT06465823 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Down Syndrome

Interventions

DRUG: Bumetanide
DRUG: Placebo

Sponsor

Stefano Vicari

Collaborators

[object Object]